Open Access. Powered by Scholars. Published by Universities.®

Diseases Commons

Open Access. Powered by Scholars. Published by Universities.®

Theses/Dissertations

University of Mississippi

Virus

Articles 1 - 2 of 2

Full-Text Articles in Diseases

Development Of An Immunoblot Assay To Detect Antibodies To Sars-Cov-2 Spike And Nucleocapsid Antigens In Serum Of Covid-19 Patients, Christian Hollis May 2023

Development Of An Immunoblot Assay To Detect Antibodies To Sars-Cov-2 Spike And Nucleocapsid Antigens In Serum Of Covid-19 Patients, Christian Hollis

Honors Theses

The coronavirus disease (COVID-19) has created one of the most world-halting events in recent world history. Its effects have reached every corner of the globe and manifested problems within each country’s healthcare and social systems. During the pandemic, many researchers have searched to develop a more robust understanding of the novel virus’s genetic and structural material. In year three since the emergence of COVID-19, these researchers hope to implement new advancements in testing and detection for the presence of the virus.

This thesis intends to produce evidence for the reliability of COVID-19 antibody tests using immunoblot assay detection. These tests …


Simian Varicella Virus Antibody Response In Recombinant Svv-Siv Immunized Primates, Kiser Horne May 2021

Simian Varicella Virus Antibody Response In Recombinant Svv-Siv Immunized Primates, Kiser Horne

Honors Theses

Since its emergence in the early 1980’s HIV has killed approximately 32 million people, and continues to kill over half a million people every year. Significant research into potential vaccines and cures for HIV has been ongoing for decades but has been largely unsuccessful. One of the more promising technologies that is being investigated to develop an HIV vaccine is recombinant vaccine technology. The study presented in this thesis aims to use simian varicella virus (SVV) and simian immunodeficiency virus (SIV) to act as a model for recombinant vaccine development. If a recombinant SVV-SIV vaccine can be proven safe and …